The company had earlier received final approval from the United States Food and Drug Administration (USFDA) to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg (USRLD: Myrbetriq ...

Shares of Lupin rose nearly 4 percent after the pharmaceutical major announced the launch of Mirabegron Extended-Release tablets (25 mg) in the United States, a drug which has over $1 billion in ...

AHMEDABAD, India, April 22, 2024--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") announces the ...

The company had earlier received final approval from the United States Food and Drug Administration (USFDA) to market Mirabegron Extended-Release Tablets USP 25 mg and 50 mg (USRLD: Myrbetriq ...

Drug maker Lupin on Monday said it has launched Mirabegron extended-release tablets (25 mg) in the US market. The Mumbai-based drug maker has introduced the medication after receiving an approval from ...

Lupin Limited announced the launch of the United States Food and Drug Administration (FDA) approved mirabegron extended-release tablets, 25 mg in US markets. Mirabegron extended-release tablets, 25 mg ...

The company has launched Mirabegron extended-release tablets in strength of 25 mg in the US market after having ... had annual sales of USD 2.42 billion in the US. Zydus shares were trading 2.9 per ...

Best Buy has a great deal on the LG Flex 42 OLED TV that you aren’t going to want to miss. The regular full retail price for this TV sits around $3,000 if you pick it up from LG. It’s also ...

AHMEDABAD, India--(BUSINESS WIRE)-- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

Mirabegron Extended-Release Tablets, 25 mg had estimated annual sales of USD 1,019 million in the U.S. (IQVIA MAT February 2024). By Online Bureau , ...